Chaim Lebovits, CEO and president of BrainStorm Cell Therapeutics in Israel, discusses the potential for the company’s developmental therapy and its implications for patients with ALS. He is joined in this segment by Rasheda Ali, daughter of Muhammad Ali, and an advisory board member for BrainStorm.
Dramatic Change in Patient with ALS and MG following Compassionate Use of BrainStorm’s NurOwn™ Cell Therapy
“We are moved by the remarkable results observed following treatment with NurOwn,” said Professor Avi Israeli, BrainStorm’s Chairman of the Board. “We are hopeful that we will continue to see this kind of improvement in all the patients participating in our current and future clinical trials.”